Who are the young bio­phar­ma lead­ers shap­ing the in­dus­try in 2022? Nom­i­nate them for End­points' spe­cial re­port

4 years ago
People
R&D

WuXi stock plum­mets, wip­ing near­ly $10B off mar­ket val­ue as US adds it to ‘un­ver­i­fied’ list

4 years ago
Manufacturing

An­a­lysts ques­tion Karyophar­m's PhI­II en­dome­tri­al can­cer da­ta as biotech will charge ahead to FDA

4 years ago
R&D

'Reg­u­la­to­ry flex­i­bil­i­ty is not war­rant­ed': FDA balks at al­low­ing Chi­na-on­ly da­ta for Eli Lil­ly's an­ti-PD-1 an­ti­body

4 years ago
China
FDA+

'Very over sol­d': Biotech brags about PhII Alzheimer's da­ta, but ex­perts are un­der­whelmed

4 years ago
R&D

Bios­plice, a for­mer an­ti-ag­ing uni­corn, slash­es staff in lat­est episode of its long fall from grace

4 years ago
People

Pfiz­er's Covid-19 vac­cine cap­tures the most an­nu­al sales of any med­ical prod­uct ever — by more than $15B

4 years ago
Coronavirus

New Or­biMed-backed biotech aims to repli­cate Ver­tex's wild­ly suc­cess­ful cys­tic fi­bro­sis pills in oth­er dis­eases

4 years ago
Financing
Startups

FDA ‘re-eval­u­at­ing’ ap­provals for TG Ther­a­peu­tics’ can­cer drug af­ter find­ing pos­si­ble in­creased risk of death

4 years ago
FDA+

On the heels of ex­posé re­veal­ing 'de­mean­ing' con­duct, Er­ic Lan­der re­signs from White House­'s top sci­ence perch

4 years ago
People

Up­dat­ed: Ed­i­tas abrupt­ly ter­mi­nates CMO Lisa Michaels, re­veal­ing lit­tle in terse SEC fil­ing

4 years ago
People
Pharma

Al San­drock notch­es an­oth­er post-Bio­gen role — and it's tak­ing him right back on­to fa­mil­iar ground

4 years ago
People

Ex­clu­sive: ARCH-backed ex­er­cise-in-a-pill start­up qui­et­ly laid off half its staff, ‘ful­ly piv­ot­ed’ in Oc­to­ber

4 years ago
Startups

Bay­er re­cruits on­col­o­gy vet Chris­tine Roth from GSK to lead on­col­o­gy busi­ness unit

4 years ago
People
Pharma

As­traZeneca ter­mi­nates US pen­sion plan — will oth­er phar­mas fol­low?

4 years ago
Pharma

Mer­ck KGaA shuf­fles or­ga­ni­za­tion to boost its CD­MO op­er­a­tion as a top ex­ec re­tires

4 years ago
Pharma
Manufacturing

Ex­perts en­cour­age bet­ter 'cy­ber hy­gien­e' as phar­ma breach­es sky­rock­et amid the pan­dem­ic

4 years ago
Pharma

AD­Cs in the pipeline: FDA spells out clin­i­cal phar­ma­col­o­gy musts for spon­sors

4 years ago
R&D
FDA+

Neu­rol­o­gists pass on Aduhelm again. Most agree with CMS de­ci­sion to lim­it cov­er­age, study finds

4 years ago
Pharma
Marketing

New AI start­up launch­es with $40M; Ob­sE­va an­nounces reg­u­la­to­ry holdup for flag­ship drug

4 years ago
News Briefing

With de­ci­sion loom­ing on J&J, Leg­end's CAR-T, an­a­lyst sees a new cham­pi­on emerg­ing in boom­ing BC­MA space

4 years ago
R&D

Break­ing with past com­ments, FDA's Richard Paz­dur telegraphs rough road ahead for Lil­ly's Chi­na-de­vel­oped can­cer drug

4 years ago
Pharma
FDA+

Months af­ter Tmu­ni­ty ground to a halt on clin­i­cal hold, cell ther­a­py pi­o­neer Oz Azam is jump­ing to a stealth start­up

4 years ago
People

Konek­sa lands new round of funds to de­vel­op app-based dig­i­tal bio­mark­er tech

4 years ago
Financing
First page Previous page 578579580581582583584 Next page Last page
A service from the Financial Times